Indian company offers low cost AIDS drugs
Kumar, S.
Lancet 357(9256): 616
2001
ISSN/ISBN: 0140-6736 PMID: 11558498 DOI: 10.1016/s0140-6736(05)71411-2Document Number: 238737
Document emailed within 0-6 h
Related Documents
Rodrigues, R.; Bogg, L.; Shet, A.; Kumar, D.Sunil.; De Costa, A. 2014: Mobile phones to support adherence to antiretroviral therapy: what would it cost the Indian National AIDS Control Programme? Journal of the International Aids Society 17: 19036Bagla, P. 2008: Scientific workplace. Indian government offers helping hand to women scientists Science 319(5869): 1470
Reynolds, T. 2000: NCI-Myriad agreement offers BRCA testing at reduced cost Journal of the National Cancer Institute 92(8): 596
Kling, B.B. 1998: Paternalism in Indian Labor: the Tata Iron and Steel Company of Jamshedpur International Labor and Working-Class History 53: 69-87
Kling, B.B. 1998: Paternalism in Indian Labor: the Tata Iron and Steel Company of Jamshedpur International Labor and Working-Class History 53: 69-87
Katan, M.B. 2005: Cost of foods fortified with plant sterols refunded by a health insurance company Nederlands Tijdschrift Voor Geneeskunde 149(7): 330-332
Hamilton, D. 1989: The cost of caring: the Metropolitan Life Insurance Company's Visiting Nurse Service, 1909-1953 Bulletin of the History of Medicine 63(3): 414-434
Tremblay, J. 1980: Prescription drugs and the aged: cost-free and cost-containment measures L'Union Medicale du Canada 109(3): 414-420
Lamberts, M.A. 1990: MSMS offers a physician's guide to AIDS/HIV in Michigan Michigan Medicine 89(2): 21
Moriya, A.; Usami, E.; Hirose, T.; Takenaka, S.; Asano, H.; Okada, K.; Adachi, S.; Yoshimura, T. 2019: Examination of Actual Medical Material Cost and Cost Reduction Related to Exposure Prevention in the Preparation of Anticancer Drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(8): 1281-1286
Mielck, A. 1988: Cost-effectiveness and cost-benefit approaches in programs designed to prevent AIDS Aids and Public Policy Journal 3(3): 19-22
Walker, D. 2003: Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base? Health Policy and Planning 18(1): 4-17
Farrington, E. 1998: Pediatric nursing Humanitarian Award recipient offers hope to children with AIDS Pediatric nursing 24(6): 614
Dickinson, D. 2008: Traditional healers, HIV/AIDS and company programmes in South Africa African Journal of Aids Research: Ajar 7(3): 281-291
Evans, A.E. 1976: Anaconda Company and Chile Copper Company v. Overseas Private Investment Corporation. Case No. 16 10 0071 72 American Journal of International Law 70(1): 135-138
1979: Technical discussions at the 20th Panamerican Health Conference. Repercussions of the cost of drugs on the cost of health: national and international problems Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 87(6): 471-493
Betegón, L.; Cotarelo, M.; Vendrell, Bén. 2012: Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines Enfermedades infecciosas y microbiologia clinica 30(8): 508-9; author reply 511-2
Gow, J.; George, G.; Grant, B. 2012: Managing the costs of HIV/AIDS: a case study of a South African contract cleaning company Development Southern Africa 29(3): 434-447
Gow, J.; George, G.; Grant, B. 2012: Managing the costs of HIV/AIDS: a case study of a South African contract cleaning company Development Southern Africa 29(3): 434-447
Tarantola, D.; Mann, J.; Mantel, C.; Cameron, C. 1994: Projecting the course of the HIV/AIDS pandemic and the cost of adult AIDS care in the world Kaplan, E H, Brandeau, M L Modeling the AIDS epidemic: Planning, policy, and prediction 3-27